<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03732131</url>
  </required_header>
  <id_info>
    <org_study_id>HUS/3198/2017</org_study_id>
    <nct_id>NCT03732131</nct_id>
  </id_info>
  <brief_title>The Finnish Faecal Microbiota Transplantation Study (FINFMT)</brief_title>
  <acronym>FINFMT</acronym>
  <official_title>Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joint Authority for Päijät-Häme Social and Health Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Helsinki</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>South Karelia, Social and Health Care District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North Karelia Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Keski-Pohjanmaa Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seinajoki Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jyväskylä Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kanta-Häme Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mikkeli Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vaasa Central Hospital, Vaasa, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lapland Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Satakunta Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kymenlaakso Social and Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kainuu Social and Health Care Joint Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Joint Authority for Päijät-Häme Social and Health Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to follow up the long term effects of faecal microbiota
      tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in
      other trials meet inclusion criteria to this study. Patients will be asked for a written
      consent. The outcome and possible side effects of the FMT will be followed by blood and feces
      samples for one year and with questionaires up to ten years after the FMT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The long term effects of FMT -questionnaire</measure>
    <time_frame>10 years</time_frame>
    <description>The questionnaire has 52 questions. Weight and height are asked and appearance of certain symptoms. The answers are mostly yes or no. The questionnaire is not validated and it is descriptive and the answers are not scored.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Faecal Microbiota Transplantation</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, feces
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Finnish patients over 18 years of age. Receiving FMT for recurring Clostridium difficile
        infektion (rCDI) which is the only indication for FMT. If experimental FMT would be given
        for any other condition after a throughout work up of a collegue of experts such a patien
        would meet inclusion criteria as well.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years age

          -  receiving FMT for rCDI or any other madical condition

          -  written consent

          -  Not included in other FMT trials

        Exclusion Criteria:

          -  Unable to provide written consent

          -  &lt; 18 years age

          -  Included in other FMT-trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Perttu Arkkila, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Head of Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Perttu Lahtinen, MD</last_name>
    <phone>+358-3-819 11</phone>
    <email>perttu.lahtinen@phhyky.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Joint Authority for Päijät-Häme Social and Health Care</name>
      <address>
        <city>Lahti</city>
        <zip>15850</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Perttu Lahtinen, MD</last_name>
      <phone>+358-3-81911</phone>
      <email>perttu.lahtinen@phhyky.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 4, 2018</study_first_submitted>
  <study_first_submitted_qc>November 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

